Details for New Drug Application (NDA): 010686
✉ Email this page to a colleague
NDA 010686 describes MODERIL, which is a drug marketed by Pfizer and is included in one NDA. Additional details are available on the MODERIL profile page.
The generic ingredient in MODERIL is rescinnamine. There is one drug master file entry for this compound. Additional details are available on the rescinnamine profile page.
The generic ingredient in MODERIL is rescinnamine. There is one drug master file entry for this compound. Additional details are available on the rescinnamine profile page.
Summary for 010686
| Tradename: | MODERIL |
| Applicant: | Pfizer |
| Ingredient: | rescinnamine |
| Patents: | 0 |
Profile for product number 003
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 0.25MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Profile for product number 006
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 0.5MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
